The Weekly Litigation News Digest is now live. Subscribe now

Aav-Mediated Gene Therapy Restoring The Otoferlin Gene - EP3911354

The patent EP3911354 was granted to Centre National DE LA Recherche Scientifique Cnrs on Apr 3, 2024. The application was originally filed on Jan 20, 2020 under application number EP20701951A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3911354

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP20701951A
Filing Date
Jan 20, 2020
Status
Granted And Under Opposition
Jun 16, 2023
Publication Date
Apr 3, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBApr 19, 2024-ADMISSIBLE
POHLMANApr 19, 2024POHLMANADMISSIBLE
WEICKMANN & WEICKMANNApr 18, 2024-ADMISSIBLE
REGENERON PHARMACEUTICALSApr 16, 2024CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6967018
DESCRIPTIONUS8137962
DESCRIPTIONUS8298818
DESCRIPTIONWO2011075838
DESCRIPTIONWO2013075008
OPPOSITIONWO03052051
OPPOSITIONWO2014193716
OPPOSITIONWO2017100791
OPPOSITIONWO2018039375
OPPOSITIONWO2018204734
OPPOSITIONWO2019165292
OPPOSITIONWO2021087296

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents